JP2014500250A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014500250A5 JP2014500250A5 JP2013537902A JP2013537902A JP2014500250A5 JP 2014500250 A5 JP2014500250 A5 JP 2014500250A5 JP 2013537902 A JP2013537902 A JP 2013537902A JP 2013537902 A JP2013537902 A JP 2013537902A JP 2014500250 A5 JP2014500250 A5 JP 2014500250A5
- Authority
- JP
- Japan
- Prior art keywords
- poly
- acetylglucosamine
- composition according
- deacetylated
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41086310P | 2010-11-06 | 2010-11-06 | |
| US61/410,863 | 2010-11-06 | ||
| US41135810P | 2010-11-08 | 2010-11-08 | |
| US61/411,358 | 2010-11-08 | ||
| PCT/US2011/059558 WO2012061803A2 (en) | 2010-11-06 | 2011-11-07 | Compositions and methods for nanopolymer-based nucleic acid delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016080377A Division JP2016164181A (ja) | 2010-11-06 | 2016-04-13 | ナノポリマーをベースとした核酸送達のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014500250A JP2014500250A (ja) | 2014-01-09 |
| JP2014500250A5 true JP2014500250A5 (https=) | 2015-02-05 |
| JP6029591B2 JP6029591B2 (ja) | 2016-11-24 |
Family
ID=46025153
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537902A Expired - Fee Related JP6029591B2 (ja) | 2010-11-06 | 2011-11-07 | ナノポリマーをベースとした核酸送達のための組成物および方法 |
| JP2016080377A Pending JP2016164181A (ja) | 2010-11-06 | 2016-04-13 | ナノポリマーをベースとした核酸送達のための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016080377A Pending JP2016164181A (ja) | 2010-11-06 | 2016-04-13 | ナノポリマーをベースとした核酸送達のための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20130287853A1 (https=) |
| EP (1) | EP2635261B1 (https=) |
| JP (2) | JP6029591B2 (https=) |
| CN (2) | CN108743562A (https=) |
| AU (3) | AU2011323078B2 (https=) |
| CA (1) | CA2816999A1 (https=) |
| ES (1) | ES2763432T3 (https=) |
| IL (1) | IL226170B (https=) |
| MX (1) | MX358050B (https=) |
| WO (1) | WO2012061803A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8871247B2 (en) | 2007-02-19 | 2014-10-28 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
| WO2011130646A1 (en) | 2010-04-15 | 2011-10-20 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly -n-acetylglucosamine nanofibers |
| WO2012061803A2 (en) * | 2010-11-06 | 2012-05-10 | Marine Polymer Technologies, Inc. | Compositions and methods for nanopolymer-based nucleic acid delivery |
| NZ732118A (en) | 2011-04-15 | 2018-11-30 | Marine Polymer Tech Inc | Treatment of disease with poly-n-acetylglucosamine nanofibers |
| CA2968160C (en) * | 2016-05-31 | 2024-01-02 | Sachiko Sato | Use of n-acetylglucosamine and derivatives thereof to treat muscle disorders |
| EP3693024A1 (en) * | 2019-02-05 | 2020-08-12 | Altona Diagnostics GmbH | Control for nucleic acid preparation and/or detection methods |
| IT202200004574A1 (it) * | 2022-03-10 | 2023-09-10 | Sergio Ammendola | Nanoparticelle di N-acetilglucosammina e loro applicazioni |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| GB0126923D0 (en) * | 2001-11-09 | 2002-01-02 | Procter & Gamble | Chitosan compositions |
| US7780873B2 (en) * | 2004-02-23 | 2010-08-24 | Texas A&M University System | Bioactive complexes compositions and methods of use thereof |
| JP2005281239A (ja) * | 2004-03-30 | 2005-10-13 | Nippon Zeon Co Ltd | 鶏用ｄｎａワクチン |
| CA2487564A1 (en) * | 2004-11-12 | 2006-05-12 | Valorisation Recherche Hscm | Folic acid-chitosan-dna nanoparticles |
| CA2646891A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Immunopotentiating compounds |
| CA2646539A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Imidazoquinoxaline compounds as immunomodulators |
| WO2008039390A2 (en) * | 2006-09-22 | 2008-04-03 | Government Of The Usa., Dept. Of Health & Human Services | Compositions and methods for chitosan enhanced immune response |
| KR100882611B1 (ko) * | 2006-11-14 | 2009-02-12 | 주식회사 키토라이프 | 표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법 |
| KR20090108723A (ko) * | 2007-01-31 | 2009-10-16 | 알러간, 인코포레이티드 | 안 약물 송달을 위한 신규한 생체적합물질 및 이의 제조방법 및 용도 |
| US20100086613A1 (en) | 2008-10-03 | 2010-04-08 | Chang-Jer Wu | Chitosan vehicle and method for making same |
| US20100105139A1 (en) * | 2008-10-27 | 2010-04-29 | Remco Alexander Spanjaard | Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents |
| WO2011140638A1 (en) * | 2010-05-10 | 2011-11-17 | Corporation De L'ecole Polytechnique De Montreal | Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1 |
| WO2012061803A2 (en) * | 2010-11-06 | 2012-05-10 | Marine Polymer Technologies, Inc. | Compositions and methods for nanopolymer-based nucleic acid delivery |
-
2011
- 2011-11-07 WO PCT/US2011/059558 patent/WO2012061803A2/en not_active Ceased
- 2011-11-07 AU AU2011323078A patent/AU2011323078B2/en not_active Ceased
- 2011-11-07 CA CA2816999A patent/CA2816999A1/en not_active Abandoned
- 2011-11-07 EP EP11838933.7A patent/EP2635261B1/en not_active Not-in-force
- 2011-11-07 MX MX2013005016A patent/MX358050B/es active IP Right Grant
- 2011-11-07 CN CN201810672707.5A patent/CN108743562A/zh active Pending
- 2011-11-07 US US13/883,527 patent/US20130287853A1/en not_active Abandoned
- 2011-11-07 ES ES11838933T patent/ES2763432T3/es active Active
- 2011-11-07 JP JP2013537902A patent/JP6029591B2/ja not_active Expired - Fee Related
- 2011-11-07 AU AU2013203247A patent/AU2013203247A1/en not_active Abandoned
- 2011-11-07 CN CN2011800636609A patent/CN103282024A/zh active Pending
-
2013
- 2013-05-05 IL IL226170A patent/IL226170B/en active IP Right Grant
-
2016
- 2016-03-15 AU AU2016201640A patent/AU2016201640A1/en not_active Abandoned
- 2016-04-13 JP JP2016080377A patent/JP2016164181A/ja active Pending
- 2016-06-24 US US15/192,356 patent/US20170128382A1/en not_active Abandoned
-
2022
- 2022-07-01 US US17/856,655 patent/US20230157971A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014500250A5 (https=) | ||
| RU2014122432A (ru) | Способ получения липидных наночастиц для доставки лекарственного средства | |
| HK1208161A1 (en) | Pharmaceutical nanoparticles showing improved mucosal transport | |
| WO2009136763A3 (en) | Nanoparticles for penetration of blood-brain barrier | |
| JP2014530219A5 (https=) | ||
| JP2015501791A5 (https=) | ||
| JP2017165748A5 (https=) | ||
| Pham et al. | Strategies for the design of orally bioavailable antileishmanial treatments | |
| WO2015152693A3 (ko) | 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물 | |
| JP2010513363A5 (https=) | ||
| JP2014508752A5 (https=) | ||
| MX342439B (es) | Metodos para producir nanoparticulas polimericas y formulaciones de ingredientes activos. | |
| WO2012170372A3 (en) | Prna mutlivalent junction domain for use in stable multivalent rna nanoparticles | |
| JP2015520197A5 (https=) | ||
| JP2014514275A5 (https=) | ||
| JP2012526134A5 (https=) | ||
| IT1393040B1 (it) | Processo per la preparazione di sospensioni stabili di nanoparticelle metalliche e sospensioni colloidali stabili cosi' ottenute | |
| MX358050B (es) | Composiciones y métodos para la entrega de ácido nucleico a base de nanopolímeros. | |
| JP2013532729A5 (https=) | ||
| MY165003A (en) | Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative | |
| JP2015501791A (ja) | 新規な遺伝子伝達用組成物 | |
| WO2010030821A3 (en) | Ibuprofen for topical administration | |
| WO2013087734A3 (en) | Functionalised silicon nanoparticles | |
| AR085527A1 (es) | Una composicon farmaceutica para tratar una enfermedad en la cavidad oral que comprende rebamipida | |
| FI3943070T3 (fi) | Pitkävaikutteisia bedakiliiniformulaatioita |